ID   Z354C_RAT               Reviewed;         560 AA.
AC   Q9EPU7;
DT   20-MAR-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   24-JUL-2024, entry version 135.
DE   RecName: Full=Zinc finger protein 354C;
DE   AltName: Full=Protein AJ18;
GN   Name=Znf354c; Synonyms=Zfp354c;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, DEVELOPMENTAL STAGE, AND INTERACTION WITH RUNX2.
RC   STRAIN=Wistar;
RX   PubMed=11278774; DOI=10.1074/jbc.m010885200;
RA   Jheon A.H., Ganss B., Cheifetz S., Sodek J.;
RT   "Characterization of a novel KRAB/C2H2 zinc finger transcription factor
RT   involved in bone development.";
RL   J. Biol. Chem. 276:18282-18289(2001).
CC   -!- FUNCTION: Transcriptional repressor that inhibits endothelial
CC       angiogenic sprouting (By similarity). Suppresses osteogenic effects of
CC       RUNX2 and may be involved in osteoblastic differentiation
CC       (PubMed:11278774). Plays a role in postnatal myogenesis, may be
CC       involved in the regulation of satellite cells self-renewal (By
CC       similarity). {ECO:0000250|UniProtKB:Q571J5,
CC       ECO:0000269|PubMed:11278774}.
CC   -!- SUBUNIT: Interacts with RUNX2. Binds consensus element OSE2
CC       (PubMed:11278774). Interacts with TRIM28 (By similarity).
CC       {ECO:0000250|UniProtKB:Q86Y25, ECO:0000269|PubMed:11278774}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11278774}. Nucleus
CC       membrane {ECO:0000250|UniProtKB:Q86Y25}. Cytoplasm
CC       {ECO:0000250|UniProtKB:Q86Y25}.
CC   -!- TISSUE SPECIFICITY: Expressed in brain. Very low expression in adult
CC       bone tissues. Overexpression suppresses alkaline phosphatase induction
CC       by BMP7. {ECO:0000269|PubMed:11278774}.
CC   -!- DEVELOPMENTAL STAGE: Expressed during osteoblast differentiation and
CC       bone development. Detected in embryonic bone formation in calvariae and
CC       tibiae. Very low expression in neonate bone tissues. Expressed in
CC       kidney and brain. {ECO:0000269|PubMed:11278774}.
CC   -!- DOMAIN: KRAB domain is essential for transcriptional repressor activity
CC       and ability to inhibit endothelial angiogenic sprouting (By
CC       similarity). Not required for nuclear targeting or for DNA binding.
CC       {ECO:0000250|UniProtKB:Q86Y25, ECO:0000269|PubMed:11278774}.
CC   -!- DOMAIN: Zinc finger region is involved in nuclear targeting and DNA-
CC       binding. {ECO:0000269|PubMed:11278774}.
CC   -!- SIMILARITY: Belongs to the krueppel C2H2-type zinc-finger protein
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF321874; AAG41994.1; -; mRNA.
DR   RefSeq; NP_076478.1; NM_023988.1.
DR   AlphaFoldDB; Q9EPU7; -.
DR   SMR; Q9EPU7; -.
DR   STRING; 10116.ENSRNOP00000000248; -.
DR   PhosphoSitePlus; Q9EPU7; -.
DR   PaxDb; 10116-ENSRNOP00000000248; -.
DR   GeneID; 78972; -.
DR   KEGG; rno:78972; -.
DR   UCSC; RGD:69405; rat.
DR   AGR; RGD:69405; -.
DR   CTD; 30944; -.
DR   RGD; 69405; Zfp354c.
DR   eggNOG; KOG1721; Eukaryota.
DR   InParanoid; Q9EPU7; -.
DR   OrthoDB; 3128539at2759; -.
DR   PhylomeDB; Q9EPU7; -.
DR   Reactome; R-RNO-212436; Generic Transcription Pathway.
DR   PRO; PR:Q9EPU7; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0031965; C:nuclear membrane; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0001525; P:angiogenesis; IEA:UniProtKB-KW.
DR   GO; GO:1903671; P:negative regulation of sprouting angiogenesis; ISS:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   CDD; cd07765; KRAB_A-box; 1.
DR   DisProt; DP01555; -.
DR   Gene3D; 6.10.140.140; -; 1.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 11.
DR   InterPro; IPR050329; GLI_C2H2-zinc-finger.
DR   InterPro; IPR001909; KRAB.
DR   InterPro; IPR036051; KRAB_dom_sf.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   PANTHER; PTHR19818:SF167; C2H2-TYPE DOMAIN-CONTAINING PROTEIN; 1.
DR   PANTHER; PTHR19818; ZINC FINGER PROTEIN ZIC AND GLI; 1.
DR   Pfam; PF01352; KRAB; 1.
DR   Pfam; PF00096; zf-C2H2; 8.
DR   Pfam; PF13465; zf-H2C2_2; 1.
DR   SMART; SM00349; KRAB; 1.
DR   SMART; SM00355; ZnF_C2H2; 11.
DR   SUPFAM; SSF57667; beta-beta-alpha zinc fingers; 6.
DR   SUPFAM; SSF109640; KRAB domain (Kruppel-associated box); 1.
DR   PROSITE; PS50805; KRAB; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 11.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 11.
PE   1: Evidence at protein level;
KW   Angiogenesis; Cytoplasm; Isopeptide bond; Membrane; Metal-binding; Nucleus;
KW   Reference proteome; Repeat; Repressor; Transcription;
KW   Transcription regulation; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..560
FT                   /note="Zinc finger protein 354C"
FT                   /id="PRO_0000280410"
FT   DOMAIN          14..84
FT                   /note="KRAB"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00119"
FT   ZN_FING         218..240
FT                   /note="C2H2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         246..268
FT                   /note="C2H2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         274..296
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         302..324
FT                   /note="C2H2-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         330..352
FT                   /note="C2H2-type 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         358..380
FT                   /note="C2H2-type 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         386..408
FT                   /note="C2H2-type 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         414..436
FT                   /note="C2H2-type 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         442..464
FT                   /note="C2H2-type 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         470..492
FT                   /note="C2H2-type 10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         498..520
FT                   /note="C2H2-type 11"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   REGION          139..167
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CROSSLNK        112
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q86Y25"
FT   CROSSLNK        169
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q86Y25"
SQ   SEQUENCE   560 AA;  64193 MW;  09249239626F22F5 CRC64;
     MAVDLLAARG TEPVTFRDVA VSFSQDEWLH LDPAQRTLYR EVMLENYSNL ASLGFQASIP
     PVIGKLQKGQ DPCMEREAPE DTCLDFQIQS EIEASSPEQD VFIEGPSRGL LKNRSTKCAY
     WKISFGELVK YERLETAQEQ EKKAHEPGAA SPKEVTSEDG IPTDPELEKP LFMNKALVSQ
     ETDPIERVPG MYHTSEKDLP QDFDLMRNFQ IYPGQKPYVC SECGKGFSQS LHLLEHKRIH
     TGEKPYKCSE CGKSFSHRSS LLAHQRTHTG EKPYKCSECE KAFGSSSTLI KHLRVHTGEK
     PYRCRECGKA FSQCSTLTVH QRIHTGEKLY KCAECDKAFN CRAKLHRHQR IHTGEKPYKC
     AECGKGYSQF PSLAEHQRLH TGGQLCQCLQ CGRTFTRVST LIEHQRIHTG QKPYQCNECG
     KTFNQYSSFN EHRKIHTGEK LYTCEECGKA FGCKSNLYRH QRIHTGEKPY QCNQCGKAFS
     QYSFLTEHER IHTGEKLYKC MECGKAYSYR SNLCRHKKVH LKERLYKWKE YGTPFMYGSS
     LAPHQRCLKG EKPEDLNSSL
//
